2156
October 122022

Water Street Invests in Global Provider of Solutions Optimizing Life Sciences Operations

Water Street Healthcare Partners announced today that it has invested in and facilitated the combination of CXV Global and Panacea Technologies. The transaction creates a leading global provider of automation and digitization solutions uniquely positioned to optimize life sciences organizations’ worldwide operations. 

View Story

Advancing Change View our 2021 Year in Review

September 142022

Water Street Appoints Vice President of Debt Capital Markets

Chicago — Water Street announced today that it has appointed Ryan Pavlik as vice president of debt capital markets. Mr. Pavlik is the newest addition to Water Street’s team as the firm expands its resources to support its growing group of companies specializing in health care services and technology, medical products and diagnostics, and pharmaceuticals and life sciences.

View Story
August 232022

Water Street Appoints Deepak Batheja Chief Information Officer

Chicago – Water Street announced today that it has appointed Deepak Batheja as chief information officer. He assumes the role from Paul T. Cottey, who announced his retirement earlier this year. Mr. Batheja will play an instrumental role in supporting Water Street’s family of companies with their goals for value creation. He also will spearhead the health care firm’s information technology, digital and cybersecurity operations. 

View Story
July 192022

Sharon Luboff Joins Water Street Healthcare Partners

Chicago – Water Street announced today that Sharon M. Luboff has joined the firm as an executive advisor. Highly regarded for leading premier businesses at C.R. Bard and Baxter Healthcare, Ms. Luboff will work with Water Street to identify opportunities to partner with founders, executives and corporations interested in growing their medical products companies. 

View Story
July 122022

Discovery Life Sciences Acquires AllCells

Huntsville, Ala. & Alameda, Calif. — Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced its acquisition of AllCells®, a leading provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products. With more than 30 years of collective cell and gene therapy (CGT) experience, AllCells and Discovery will focus on providing revolutionary products and services with greater speed and reliability to satisfy the entire CGT continuum ─ from basic discovery through commercialization. 

View Story

Subscribe to Water Street News

To receive Water Street news via email,
please complete the form below.

Privacy Policy

You’ve just been sent an email to confirm your email address. Please click on the link in the email to activate your subscription.

If you do not receive an email from us within a few minutes, please check your spam folder. If our email did not come through to you, please click on this link, news@waterstreet.com.

Something went wrong. If you are seeing this error, please let us know, and we will get it fixed asap.